Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Leases (2019 - 2025)

Sunshine Biopharma's Current Leases history spans 5 years, with the latest figure at $215637.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 3.79% year-over-year to $215637.0; the TTM value through Dec 2025 reached $215637.0, up 3.79%, while the annual FY2025 figure was $215637.0, 3.79% up from the prior year.
  • Current Leases reached $215637.0 in Q4 2025 per SBFM's latest filing, down from $218053.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $222496.0 in Q2 2025 to a low of $114452.0 in Q2 2024.
  • Average Current Leases over 4 years is $155924.1, with a median of $122146.0 recorded in 2023.
  • Peak YoY movement for Current Leases: decreased 6.3% in 2024, then surged 94.4% in 2025.
  • A 4-year view of Current Leases shows it stood at $123026.0 in 2022, then dropped by 3.54% to $118670.0 in 2023, then soared by 75.07% to $207756.0 in 2024, then rose by 3.79% to $215637.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Current Leases are $215637.0 (Q4 2025), $218053.0 (Q3 2025), and $222496.0 (Q2 2025).